Drug intelligence / Profile preview

Qingpeng

Development stage: Unknown
Lead developer: Beijing University of Chinese Medicine
Administration: Topical

Overview

Qingpeng is a traditional Tibetan medicine (TTM) formulation primarily used as a topical ointment for its anti-inflammatory and analgesic properties. It is composed of several herbal and mineral ingredients, including *Aconitum pendulum*, *Oxytropis falcata*, and *Tinospora sinensis*. The ointment is indicated for the treatment of various inflammatory and painful conditions such as rheumatoid arthritis, osteoarthritis, gouty arthritis, and skin conditions like eczema and psoriasis. In clinical settings, it has also been investigated for the treatment of post-stroke shoulder-hand syndrome to reduce pain and swelling and improve limb function.

Brand names: Qingpeng OintmentQingpeng Gao
Other names: Qingpeng ointment

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Qingpeng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingpeng.